NDC 62756-970 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII 1 recall

Product NDC62756-970

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA201633
Marketed since
July 18, 2017
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (2)

Package NDCDescriptionSince
62756-970-643 BLISTER PACK in 1 CARTON (62756-970-64) / 10 TABLET in 1 BLISTER PACKJul 18, 2017
62756-970-8330 TABLET in 1 BOTTLE (62756-970-83)Jul 18, 2017

Recalls mentioning this NDC

Other Buprenorphine and Naloxone products